Hospice Medical Director Liability: Whose Judgment Is Behind the Signature?

Hospice medical director fraud liability can arise when a physician signs terminal-illness certifications without reviewing the patient’s condition, signs an opinion the physician does not believe, or uses information the physician knows is wrong. A nurse may have documented improvement while the certification packet described decline. A medical director may have recommended discharge while management insisted on keeping the patient. In hospice eligibility fraud, the signature is where those accounts meet. Medicare pays the bill, and patients can be kept in hospice because management wants the revenue.

What Are the Responsibilities of a Hospice Medical Director?

A hospice medical director exercises clinical judgment about whether a patient’s illness supports a prognosis of six months or less if it runs its normal course. The certification must have supporting clinical information and an individualized physician narrative.

Under Medicare’s certification requirements, the physician attests to composing that narrative from a review of the patient’s medical record or, when applicable, an examination. The narrative must describe this patient’s circumstances. A checkbox or standard paragraph used for every patient cannot do that work.

Nursing assessments, including the underlying vital signs, supply information for the judgment. The physician’s narrative explains why that information supports the prognosis. We build the case around what the nurse observed, what reached the physician and what the physician signed.

Who Determines Eligibility for Hospice?

For the first benefit period, the hospice medical director or physician member of the interdisciplinary group certifies terminal illness, together with the patient’s attending physician when the patient has a qualifying attending physician. For subsequent periods, the hospice physician recertifies.

Only a medical doctor or doctor of osteopathy may certify or recertify terminal illness for Medicare hospice.

Can a Nurse Practitioner Certify a Patient for Hospice?

A nurse practitioner can conduct the required hospice face-to-face encounter, but cannot certify or recertify terminal illness. The encounter supplies clinical findings to the certifying physician.

The handoff matters: what the practitioner observed, what reached the physician and how the physician used it.

What Are the CMS Face-to-Face Requirements for Hospice Care?

The face-to-face requirement begins before the third benefit period and applies to each later recertification. A hospice physician or nurse practitioner conducts the encounter, and the certifying physician’s narrative must explain why its clinical findings support continued eligibility.

The requirement follows the patient’s cumulative hospice stay across providers. A transfer therefore carries that history with it. The encounter findings and the recertification narrative should tell a connected clinical story: what the practitioner found and why those findings support the terminal prognosis.

What Happens If a Hospice Patient Lives Longer Than Six Months?

A patient can continue receiving hospice care when the required recertifications support continued eligibility. Medicare provides two 90-day benefit periods followed by unlimited 60-day periods, each requiring certification.

The Centers for Medicare & Medicaid Services’ hospice coverage manual recognizes that life-expectancy predictions are inexact. Continued eligibility turns on the patient’s condition at each recertification. Improvement, continued decline and findings from the required encounter belong in that decision.

Hospice Medical Director Liability for a Signed Certification

Hospice medical director liability for a signed certification depends on the judgment behind it and the physician’s knowledge. In its AseraCare decision, the Eleventh Circuit identified concrete ways to show a false clinical judgment.

One is a physician who signs without reviewing the records or otherwise becoming familiar with the patient’s condition. Another is a physician who does not actually believe the patient is terminally ill. The signed statement and the physician’s own understanding then tell different stories.

The court also pointed to a physician relying on information the physician knew, or had reason to know, was wrong. A medical expert could show that no reasonable physician would have reached that prognosis from the chart.

That makes contemporaneous records especially useful. A physician’s question about a missing diagnosis, an objection during a team meeting or a request for more information can show what remained unresolved when the certification was signed. We work with the insider to show how those unresolved concerns became signed certifications and Medicare claims.

How Courts Treat a Disputed Hospice Prognosis

Courts differ on how much a disagreement between medical experts can show about a false certification, as AseraCare and the Care Alternatives decision illustrate. We work through that issue with hospice fraud whistleblower lawyers, using the insider’s account of what was reviewed, withheld or changed.

What the Physician Received Before Signing

The information reaching the physician can be central to a hospice fraud case. The health care provider assembles the clinical record, obtains the certification and submits the claim. The Curo allegations show why a case can reach the company that controlled the information given to the physician.

In its case against Curo Health Services, the Justice Department alleged that the company failed to ensure certifying physicians received or adequately considered complete and accurate information about patients’ conditions. The allegation reaches the preparation and delivery of the information, as well as its review. Curo was among the companies covered by the Kindred settlement announced in 2024.

The Evercare complaints describe how the information and the signature could become disconnected. A former employee alleged that a medical director signed stacks of terminal-illness certifications during interdisciplinary meetings without reviewing clinical information. The employee also alleged that physicians recertified patients on a manager’s direction instead of clinical grounds.

Those allegations describe different participants with different knowledge. A physician who received an incomplete packet, a physician who ignored contrary information and a manager who decided what the packet would contain each occupies a different place in the same process. We work with the insider to establish who controlled that process and connect those decisions to the claims.

When Nonclinical Staff Control the Decision

Management control becomes visible when a clinical recommendation runs into a census decision. In the government’s Evercare complaint, the alleged barriers reached both admission and departure: staff needed managerial approval to reject a referral, and management resisted letting patients leave.

The complaint quoted an instruction about a patient’s requested revocation of hospice:

In that account, a patient asked to leave hospice, and management’s answer turned on the census. Looking only at the signed certification leaves that business decision out of view.

The government also alleged that Evercare’s internal audits found charts without documentation supporting terminal prognosis and that nursing notes were frequently completed after the day of the visit. An audit showing missing support and a later certification create questions about what information reached the physician and how the company responded.

Evercare agreed to an $18 million settlement in 2016 over alleged claims for patients whose records did not support terminal illness. The alleged practices behind those claims included unreliable nursing documentation and discouraged discharges. The company’s revenue depended on patients staying enrolled.

Why the Census Can Put Pressure on Clinical Judgment

Medicare pays routine hospice care by the enrolled day, while the cost of care varies across a stay. Costs tend to be higher around admission and death, with less intensive care in between. Keeping a patient through that middle period can keep revenue coming while service needs are lower.

The Office of Inspector General examined that incentive in Medicare Hospices Have Financial Incentives To Provide Care in Assisted Living Facilities, published in 2015. Its analysis of Medicare hospice claims from 2007 through 2012 found longer stays in assisted living than in other settings. Hospices typically provided fewer than five hours of visits per week while receiving about $1,100 per week for each beneficiary receiving routine home care in assisted living.

The report explained what that payment arrangement rewards:

The medical director’s recertification sits inside that business model. The individual clinical decision determines whether a patient continues to qualify, while managers may be measuring the same patient as another enrolled day. The Evercare allegations show why instructions about keeping the census up belong beside the clinical record.

Referral relationships can put another incentive around the role. In the Good Shepherd Hospice case, the government alleged that the company chose medical directors for their ability to refer patients, particularly through nursing-home connections.

In the Tapestry Hospice case, the government alleged that medical-director pay rose when referrals increased and fell when referrals stopped. Medical-director compensation and referral arrangements deserve their own examination. Here, the question is how that relationship affected what the physician reviewed, decided and signed.

The Records Behind a Medical Director’s Signature

For hospice fraud whistleblowers in clinical care, compliance or billing, the story often crosses departments. Nursing assessments, physician questions and internal warnings can tell a different story from the certification used for Medicare billing. We build that healthcare fraud case with the insider who knows how those decisions were made.

The timing matters because a completed chart viewed later may contain information that was missing when the physician signed. In the Evercare allegations, the internal audits themselves identified delayed documentation. The distinction is visible when the original clinical observation, the entry date and the certification are considered together.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Your knowledge of how the chart became a signed certification supplies context a claims review cannot show on its own.

When You Know What Was Behind the Signature

If you saw a certification signed without review, clinical findings kept from a physician or a discharge decision overruled to protect the census, speak with our whistleblower experts about what happened inside your hospice. You know what happened between the team meeting and the physician’s signature; we work beside you to turn that knowledge into a case and bring in hospice fraud whistleblower lawyers who understand certification disputes.